Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.05 | 48.32 |
| PEG Ratio (TTM) | 0.08 | 0.31 |
| P/S Ratio (TTM) | 0.27 | 3.59 |
| P/B Ratio (TTM) | 1.44 | 2.46 |
| P/FCF Ratio (TTM) | -0.90 | 35.62 |
| Price to 5YR AVG Earnings Ratio | N/A | 51.60 |
| Price to 5YR AVG FCF Ratio | N/A | 29.61 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -11.80% | 1.32% |
| ROE (TTM) | -42.67% | -3.04% |
| Net Profit Margin (TTM) | -8.76% | -1.57% |
| ROIC 5YR AVG | N/A | 137.75% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -133.12% | -368.70% | N/A |
| Revenue | 0.52% | 107.65% | N/A |
| Net Income | -137.73% | -61.65% | N/A |
| Cash Flow | -82.73% | -174.01% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 8.27 | 2.90 |
| Quick Ratio (TTM) | 2.58 | 2.87 |
| D/E Ratio (TTM) | 2.88 | 1.33 |
| Interest Coverage (TTM) | -2.31 | -0.49 |
| Piotroski F-Score | 5 | 5 |
| Altman Z-Score | 0.91 | 4.04 |
| LTL to 5YR AVG FCF | N/A | 51.70 |
| Shares Outstanding Growth 5YR AVG | N/A | 66.37% |